Publication | Closed Access

Neutrophil:Lymphocyte Ratio and Intraoperative Use of Ketorolac or Diclofenac are Prognostic Factors in Different Cohorts of Patients Undergoing Breast, Lung, and Kidney Cancer Surgery

Surgical OncologyPatients Undergoing BreastMedicineCancer ManagementMetronomic TherapySurgeryIntraoperative UseOncologyRadiation OncologyCancer ResearchKidney Cancer Surgery